BARCLAYS PLC - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 4 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$402,000
-82.8%
105,821
-77.0%
0.00%
-100.0%
Q4 2019$2,336,000
+97.0%
459,214
+95.6%
0.00%0.0%
Q3 2019$1,186,000
-23.8%
234,749
-7.0%
0.00%0.0%
Q2 2019$1,557,000
+135.9%
252,401
+77.5%
0.00%
Q1 2019$660,000
-1.3%
142,228
-10.8%
0.00%
Q4 2018$669,000
-61.8%
159,492
-42.9%
0.00%
-100.0%
Q3 2018$1,753,000
-21.3%
279,435
+0.8%
0.00%
-50.0%
Q2 2018$2,227,000
+49.3%
277,106
+38.6%
0.00%
+100.0%
Q1 2018$1,492,000
+56.9%
199,964
+25.1%
0.00%
Q4 2017$951,000
-23.1%
159,786
-4.8%
0.00%
-100.0%
Q3 2017$1,236,000
+23.4%
167,800
+13.5%
0.00%
+100.0%
Q2 2017$1,002,000
+7.5%
147,778
+49.6%
0.00%0.0%
Q1 2017$932,000
+78.5%
98,760
+63.4%
0.00%
Q4 2016$522,000
+82.5%
60,455
+34.1%
0.00%
Q3 2016$286,000
+2500.0%
45,089
+1570.0%
0.00%
Q2 2016$11,000
-78.4%
2,700
-78.6%
0.00%
Q1 2016$51,000
+64.5%
12,592
+134.5%
0.00%
Q4 2015$31,000
-71.6%
5,369
-75.5%
0.00%
Q3 2015$109,000
-91.1%
21,886
-87.5%
0.00%
-100.0%
Q2 2015$1,223,000
+42.9%
174,869
+2.2%
0.00%
Q1 2015$856,000
+215.9%
171,081
+342.7%
0.00%
Q4 2014$271,000
+129.7%
38,649
+64.4%
0.00%
Q3 2014$118,000
-23.4%
23,512
-38.9%
0.00%
Q2 2014$154,000
-45.8%
38,465
-45.5%
0.00%
Q1 2014$284,000
-11.0%
70,514
+10.8%
0.00%
Q4 2013$319,000
+50.5%
63,625
+50.6%
0.00%
Q3 2013$212,000
-40.4%
42,245
-47.0%
0.00%
Q2 2013$356,00079,7190.00%
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q2 2020.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders